These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 16114503)

  • 1. Preparation and characterization of solid dispersions of itraconazole by using aerosol solvent extraction system for improvement in drug solubility and bioavailability.
    Lee S; Nam K; Kim MS; Jun SW; Park JS; Woo JS; Hwang SJ
    Arch Pharm Res; 2005 Jul; 28(7):866-74. PubMed ID: 16114503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Itraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogs.
    Yin X; Daintree LS; Ding S; Ledger DM; Wang B; Zhao W; Qi J; Wu W; Han J
    Drug Des Devel Ther; 2015; 9():2801-10. PubMed ID: 26060397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion--Part I.
    Verreck G; Six K; Van den Mooter G; Baert L; Peeters J; Brewster ME
    Int J Pharm; 2003 Jan; 251(1-2):165-74. PubMed ID: 12527186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusion processing of itraconazole solid dispersions by kinetisol dispersing: a comparative study to hot melt extrusion.
    DiNunzio JC; Brough C; Miller DA; Williams RO; McGinity JW
    J Pharm Sci; 2010 Mar; 99(3):1239-53. PubMed ID: 19681106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of novel itraconazole-loaded solid dispersion without crystalline change with improved bioavailability.
    Park YJ; Xuan JJ; Oh DH; Balakrishnan P; Yang HJ; Yeo WH; Lee MK; Choi HG; Yong CS
    Arch Pharm Res; 2010 Aug; 33(8):1217-25. PubMed ID: 20803125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion, Part II.
    Six K; Berghmans H; Leuner C; Dressman J; Van Werde K; Mullens J; Benoist L; Thimon M; Meublat L; Verreck G; Peeters J; Brewster M; Van den Mooter G
    Pharm Res; 2003 Jul; 20(7):1047-54. PubMed ID: 12880291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of emulsified solid dispersions containing docetaxel.
    Chen Y; Shi Q; Chen Z; Zheng J; Xu H; Li J; Liu H
    Arch Pharm Res; 2011 Nov; 34(11):1909-17. PubMed ID: 22139690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes.
    Yan YD; Sung JH; Kim KK; Kim DW; Kim JO; Lee BJ; Yong CS; Choi HG
    Int J Pharm; 2012 Jan; 422(1-2):202-10. PubMed ID: 22085435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and pharmacokinetic study of itraconazole solid dispersions prepared by solvent-controlled precipitation and spray-dry methods.
    Sim T; Lim C; Lee JW; Kim DW; Kim Y; Kim M; Choi S; Choi HG; Lee ES; Kim KS; Kang W; Oh KT
    J Pharm Pharmacol; 2017 Dec; 69(12):1707-1715. PubMed ID: 28872678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of ternary solid dispersions of itraconazole, PEG 6000, and HPMC 2910 E5.
    Janssens S; de Armas HN; Roberts CJ; Van den Mooter G
    J Pharm Sci; 2008 Jun; 97(6):2110-20. PubMed ID: 17847067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process.
    Ha ES; Kim JS; Baek IH; Yoo JW; Jung Y; Moon HR; Kim MS
    Drug Des Devel Ther; 2015; 9():4269-77. PubMed ID: 26345723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
    Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
    Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flocculated amorphous itraconazole nanoparticles for enhanced in vitro supersaturation and in vivo bioavailability.
    Miller MA; DiNunzio J; Matteucci ME; Ludher BS; Williams RO; Johnston KP
    Drug Dev Ind Pharm; 2012 May; 38(5):557-70. PubMed ID: 21961961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Itraconazole Tablets Containing Viscous KinetiSol Solid Dispersions: In Vitro and In Vivo Analysis in Dogs.
    Keen JM; LaFountaine JS; Hughey JR; Miller DA; McGinity JW
    AAPS PharmSciTech; 2018 Jul; 19(5):1998-2008. PubMed ID: 29192405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced solubility and oral bioavailability of itraconazole by combining membrane emulsification and spray drying technique.
    Choi YK; Poudel BK; Marasini N; Yang KY; Kim JW; Kim JO; Choi HG; Yong CS
    Int J Pharm; 2012 Sep; 434(1-2):264-71. PubMed ID: 22643224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amorphous compositions using concentration enhancing polymers for improved bioavailability of itraconazole.
    DiNunzio JC; Miller DA; Yang W; McGinity JW; Williams RO
    Mol Pharm; 2008; 5(6):968-80. PubMed ID: 19434851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement.
    Yun F; Kang A; Shan J; Zhao X; Bi X; Li J; Di L
    Int J Pharm; 2014 Apr; 465(1-2):436-43. PubMed ID: 24576810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Polyvinyl Alcohol as a Solubility-Enhancing Polymer for Poorly Water Soluble Drug Delivery (Part 1).
    Brough C; Miller DA; Keen JM; Kucera SA; Lubda D; Williams RO
    AAPS PharmSciTech; 2016 Feb; 17(1):167-79. PubMed ID: 26637232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of rapidly disintegrating tablets containing itraconazole solid dispersions.
    Oshima T; Sonoda R; Ohkuma M; Sunada H
    Chem Pharm Bull (Tokyo); 2007 Nov; 55(11):1557-62. PubMed ID: 17978511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.